KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Calumet (CLMT) Gains from Sales and Divestitures (2022 - 2025)

Calumet (CLMT) reported Gains from Sales and Divestitures of $898911.0 for Q4 2025, up 338.33% year-over-year from $205074.0 in Q4 2024, and up 338.33% on a QoQ basis from $205074.0 in Q4 2024.

Calumet (CLMT) has 4 years of Gains from Sales and Divestitures data on file, last reported at $898911.0 in Q4 2025.

  • Quarterly Gains from Sales and Divestitures rose 338.33% year-over-year to $898911.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $898911.0 (up 338.33% YoY) and the FY2025 annual result came in at $898911.0, up 338.33% from the prior year.
  • Gains from Sales and Divestitures improved to $898911.0 in Q4 2025 per CLMT's latest filing, from $205074.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $1.7 million in Q4 2022 and bottomed at $205074.0 in Q4 2024.
  • The 4-year median for Gains from Sales and Divestitures is $1.0 million (2023), against an average of $988827.5.
  • The widest annual swing landed in 2024, when Gains from Sales and Divestitures plunged 82.08%; it then jumped 338.33% in 2025.
  • Tracing CLMT's Gains from Sales and Divestitures over 4 years: stood at $1.7 million in 2022, then slumped by 32.94% to $1.1 million in 2023, then sank by 82.08% to $205074.0 in 2024, then jumped by 338.33% to $898911.0 in 2025.
  • Per Business Quant, the three latest CLMT Gains from Sales and Divestitures figures stand at $898911.0 (Q4 2025), $205074.0 (Q4 2024), and $1.1 million (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Linde 230.79 Bn 226.84 Bn 4.26 Bn
2 Chemical & Mining Co Of Chile 127.66 Bn 124.93 Bn 778.60 Mn
3 Sherwin Williams 72.51 Bn 72.30 Bn 2.78 Bn
4 Ecolab 70.96 Bn 70.34 Bn 1.85 Bn
5 Air Products & Chemicals 62.15 Bn 63.70 Bn 987.40 Mn
6 Ppg Industries 25.04 Bn 23.57 Bn 1.66 Bn
7 LyondellBasell Industries 21.62 Bn 21.73 Bn 701.00 Mn
8 Albemarle 20.26 Bn 19.42 Bn 500.97 Mn
9 DuPont de Nemours 19.45 Bn 19.56 Bn 602.00 Mn
10 Calumet 3.14 Bn 3.21 Bn -87.50 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 898,911.00
Dec 31, 2025 898,911.00
Dec 31, 2024 205,074.00
Dec 31, 2024 205,074.00
Dec 31, 2023 1.14 Mn
Dec 31, 2023 1.14 Mn
Dec 31, 2022 1.71 Mn
Dec 31, 2022 1.71 Mn